Diabetes & Metabolism

Papers
(The median citation count of Diabetes & Metabolism is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Variable incidence of ketoacidosis in youth with type 1 diabetes onset during COVID-19 pandemic peaks in France69
Glycemic Risk Index (GRI) variability in type 1 diabetes adults with HbA1c ≤ 7%: Insights for clinical evaluation and intervention64
Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach60
Comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in preventing Alzheimer's disease, vascular dementia, and other dementia types among patients with type 2 diabetes56
Insulin pump initiation in outpatient settings: When technology facilitates new healthcare organizations43
Prevention of exercise-induced hypoglycemia in 12 patients with type 1 diabetes running the Paris Marathon using continuous glucose monitoring: A prospective, single-center observational study34
Elevation of hemoglobin A1c increases the risk of decline in left ventricular systolic function among patients with coronary artery disease34
Impact of BMI on prevalence of coronary atherosclerotic lesions in non-smoking premenopausal diabetic women: A monocentric study34
Association between diabetes and stress-induced hyperglycemia with skeletal muscle gene expression of INSR in critically ill patients: A prospective cohort study33
Discontinuation of hemodialysis after correction of a major hypothyroidism episode, A case report33
Editorial board31
Analysis of glycemic control in diabetic patients by monitoring HbA1c levels before, during and after Covid-19 confinement in Auvergne, France30
Pancreas allograft rejection occurring after ChAdOx1 nCoV-19 vaccine29
Prognosis associated with initial care of increased fasting glucose in early pregnancy: A retrospective study27
Residual risk associations between initial hyperglycemia and adverse pregnancy outcomes in a large cohort including 6709 women with gestational diabetes27
Contents - page 127
The association between metformin treatment and COVID-19 outcomes according to metformin continuation during hospitalisation25
Increased risk of renal events in people with diabetic foot disease: A longitudinal observational study25
Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: A prospective cohort study25
Effect of high-dose mineralocorticoid receptor antagonist eplerenone on urinary albumin excretion in patients with type 2 diabetes and high cardiovascular risk: Data from the MIRAD trial25
Compared impact of diabetes on the risk of heart failure from acute myocardial infarction to chronic coronary artery disease25
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies24
SGLT2 inhibitors and the autonomic nervous system in diabetes: A promising challenge to better understand multiple target improvement24
Cost analysis of continuous glucose monitoring in patients hospitalized in a diabetes department24
Discovery of a TRMT10A mutation in a case of atypical diabetes: Case report23
Use of SGLT2 inhibitors after bariatric/metabolic surgery: Risk/benefit balance22
Lower limb amputations: protection with GLP-1 receptor agonists rather than increased risk with SGLT2 inhibitors?22
Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: A comprehensive review ranging from sulphonylureas to SGLT2 inhibitors22
Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction21
Antidiabetic agents and risk of atrial fibrillation/flutter: A comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonists21
Measuring phosphate levels in diabetic ketoacidosis: A sacred cow?21
Lower trabecular bone score in type 2 diabetes mellitus: A role for fat mass and insulin resistance beyond hyperglycaemia20
Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes20
Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial20
Association of multiple sclerosis with incident diabetes: A nationwide cohort study19
Effect of ipragliflozin on endothelial dysfunction in patients with type 2 diabetes and chronic kidney disease: A randomized clinical trial (PROCEED)19
Diuretics and risk of major adverse limb events in patients with type-2 diabetes: An observational retrospective study19
Metformin treatment is associated with an increase in bone mineral density in type 2 diabetes mellitus patients in China: A retrospective single center study18
Association between glycemic status and age-related macular degeneration: A nationwide population-based cohort study18
Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus18
Incidence of new-onset type 1 diabetes during Covid-19 pandemic: A French nationwide population-based study18
Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: A randomized controlled trial18
Exposure to persistent organic pollutants and the risk of type 2 diabetes: a case-cohort study17
Physical activity and diabetes mortality in people with type 2 diabetes: a prospective cohort study of 0.5 million US people16
Smoking and diabetes interplay: A comprehensive review and joint statement15
A glycosylated hemoglobin A1c above 6% (42 mmol/mol) is associated with a high risk of developing Cystic Fibrosis-Related Diabetes and a lower probability of weight gain in both adults and children wi15
Response to “A high lean body mass is not protecting from type 2 diabetes in the presence of a high body fat mass”15
The transformative role of artificial intelligence in diabetes care and research15
Baseline and longitudinal trajectories of body-mass index and all-cause mortality among patients with type 2 diabetes15
Prevalence and risk of diabetic complications in young-onset versus late-onset type 2 diabetes mellitus15
High serum total bilirubin as a potential protective factor for gestational diabetes mellitus: A retrospective cohort study of 92,885 Chinese pregnant women15
A healthful plant-based diet is associated with lower type 2 diabetes risk via improved metabolic state and organ function: A prospective cohort study15
Editorial board14
Menopausal hormone therapy decreases the likelihood of diabetes development in peri‑menopausal individuals with prediabetes14
Sommaire13
Contents13
Association between sodium glucose co-transporter 2 inhibitors and incident glaucoma in patients with type 2 diabetes: A multi-institutional cohort study in Taiwan13
Association of podocyte ultrastructural changes with proteinuria and pathological classification in type 2 diabetic nephropathy13
Massive lactic acidosis and ketoacidosis with glucagon deficiency in a chronic alcoholic patient13
Weight loss therapy and addiction: Increased risk after bariatric surgery but reduced risk with GLP-1 receptor agonists11
Contents11
Statin use in patients with diabetes amid COVID-19 pandemic11
Epidemiology of major amputation following diabetic foot ulcer: Insights from recent nationwide data in the french national health registry (SNDS)11
Contents11
Continuous glucose monitoring‑derived time in range and CV are associated with elevated risk of adverse kidney outcomes for patients with type 2 diabetes11
Editorial board11
Increased mortality risk associated with statins in the CORONADO study11
Sommaire - page 110
Remission of necrobiosis lipoidica diabeticorum with a JAK1/2 inhibitor: A case report10
Impaired auditory neural performance, another dimension of hearing loss in type-2 diabetes mellitus10
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients10
Contents - page 110
Contents10
French National Authority for Health assessment of metabolic surgery for type 2 diabetes remission—A meta-analysis in patients with class I to III obesity9
Leisure-time physical activity and mortality risk in type 2 diabetes: A nationwide cohort study9
Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV rand9
The switch from rapid-acting to concentrated regular insulin improves glucose control in type 2 diabetes patients on pump therapy: A cohort survey9
Lifestyle changes in patients with morbid obesity and type 2 diabetes mellitus during the COVID-19 pandemic9
Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study9
Fewer Type A personality traits in type 2 diabetes patients with diabetic foot ulcer9
Gestational diabetes is associated with SARS-CoV-2 infection during pregnancy: A case-control study9
Immune checkpoint inhibitors and diabetes: Mechanisms and predictors8
Impact of gender on relative rates of cardiovascular events in patients with diabetes8
Glyburide therapy for gestational diabetes: Glycaemic control, maternal hypoglycaemia, and treatment failure8
Cutaneous hypersensitivity reaction to dulaglutide: A case report of an allergic reaction8
No association of endothelial lipase and aldose reductase polymorphisms with proliferative diabetic retinopathy: Results of the French prospective multicenter REDIAGEN study8
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus8
Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood8
Perirenal fat and chronic kidney disease in type 2 diabetes: The mediation role of afferent arteriolar resistance7
Association of diabetes and outcomes in patients with COVID-19: Propensity score-matched analyses from a French retrospective cohort7
Association between adipose deposition and mortality among adults without major cardiovascular risk factors7
Fasting serum copeptin and asymptomatic peripheral artery disease: No association in patients with type 1 diabetes mellitus7
Cardiovascular risks of periodontitis and oral hygiene indicators in patients with diabetes mellitus7
Insulin-based or non-insulin-based insulin resistance indicators and risk of long-term cardiovascular and all-cause mortality in the general population: A 25-year cohort study7
Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design7
Improved dyspeptic symptoms of type 1 diabetes adults with gastroparesis on hybrid closed loop system: A case series7
Glucagon like peptide-1 receptor agonists in type 1 diabetes7
Phthalates exposure, biological aging, and increased risks of insulin resistance, prediabetes, and diabetes in adults with metabolic dysfunction-associated steatotic liver disease7
Associations of young onset age and genetic risk of beta cell dysfunction with glycaemic progression in individuals with type 2 diabetes7
Liraglutide reduces plasma PCSK9 in patients with type 2 diabetes not treated with statins6
Editorial board6
Eye disorders other than diabetic retinopathy in patients with diabetes6
Diabetic ketoacidosis and mortality in COVID-19 infection6
Risks of carpal tunnel syndrome and carpal tunnel release surgery in users of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A target trial emulation study6
Protection by metformin against severe Covid-19: An in-depth mechanistic analysis6
Contents6
Editorial board6
Dulaglutide and insulin microsecretion in people with type 1 diabetes (DIAMOND-GLP-1): A randomized double-blind placebo-controlled trial6
Comment on Gaudillère et al. Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme [1]6
Pregnant type 1 diabetes women with rises in C-peptide display higher levels of regulatory T cells: A pilot study6
Bidirectional relationship between diabetes and pulmonary function: a systematic review and meta-analysis6
Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement6
The obesity treatment dilemma: Why dieting is both the answer and the problem? A mechanistic overview6
Association between blood urea nitrogen-to-creatinine ratio and insulin sensitivity6
Early continuous glucose monitoring for predicting remission of type 2 diabetes 1 year after bariatric surgery6
Metformin treatment is associated with improved survival in diabetic patients hospitalized with acute heart failure: A prospective observational study using the Korean acute heart failure registry dat5
Editorial board5
Role of monogenic diabetes genes on beta cell function in Italian patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 135
Diabetes is not associated with COVID-19-related mortality in older institutionalized people5
Non-dioxin-like polychlorinated biphenyls (NDL-PCBs) dietary exposure is associated with an increased risk of type 2 diabetes in the European prospective investigation into cancer and nutrition (EPIC)5
Is plasma 16:0 ceramide a marker of cardiovascular risk?5
Understanding the link between different types of maternal diabetes and the onset of autism spectrum disorders5
A very rare cause of markedly elevated CA 19–9: Glucagon-like peptide-1 receptor agonists5
Comment on “Elevated triglyceride–glucose index predicts risk of incident ischemic stroke: The Rural Chinese cohort study”5
SGLT2i as fourth-line therapy and risk of mortality, end-stage renal diseases and cardiovascular diseases in patients with type 2 diabetes mellitus5
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus5
Pre-gestational diabetes and the risk of congenital heart defects in the offspring: A French nationwide study5
Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: A narrative review5
Periodontitis adversely affects lipoprotein subfractions – results from the cohort study SHIP-TREND5
Editorial board5
Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs5
Medial arterial calcification of the lower limbs in diabetes: Time for awareness? A short narrative review4
Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?4
Associations of type 2 diabetes and the risk of migraine in Chinese populations4
Diabetes mellitus in the era of climate change4
Canagliflozin could improve the levels of renal oxygenation in newly diagnosed type 2 diabetes patients with normal renal function4
Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020–20214
Association between fatty liver index and risk of end-stage renal disease stratified by kidney function in patients with type 2 diabetes: A nationwide population-based study4
Elevated triglyceride–glucose index predicts risk of incident ischaemic stroke: The Rural Chinese cohort study4
One-hour post-load glucose is associated with biopsy-proven metabolic dysfunction-associated steatotic liver disease in obese individuals4
Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis4
The discovery of insulin in 1914: Georg Zülzer, from Berlin, and Camille Reuter, the forgotten chemist from Luxembourg4
Low hemoglobin, even within the normal range, is associated with diabetic kidney disease4
Lipoatrophic diabetes in familial partial lipodystrophy type 2: From insulin resistance to diabetes3
Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?3
Liraglutide and sitagliptin have no effect on intestinal microbiota composition: A 12-week randomized placebo-controlled trial in adults with type 2 diabetes3
Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring3
Plasma 16:0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes3
Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes3
Increased risk of incident mental disorders in adults with new-onset type 1 diabetes diagnosed after the age of 19: A nationwide cohort study3
Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes3
Hyperglycemia-related anxiety during competition in an elite athlete with type 1 diabetes: A case report3
Effect of glucagon-like peptide 1 receptor agonists on the renal protection in patients with type 2 diabetes: A systematic review and meta-analysis3
Dominant PDX1 deficiency causes highly penetrant diabetes at different ages, associated with obesity and exocrine pancreatic deficiency: Lessons for precision medicine3
Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: Propensity score analysis of a territory-wide cohort in Hong Kong3
MG53 marks poor beta cell performance and predicts onset of type 2 diabetes in subjects with different degrees of glucose tolerance.3
Healing of diabetic foot ulcers is independently associated with the use of angiotensin receptor blockers but not with those of diuretics and angiotensin conversion enzyme inhibitors3
Use of glucagon-like peptide-1 receptor agonists in people with history of acute pancreatitis: TriNetX analysis3
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes3
Glycemia Risk Index (GRI) and international glucose targets before and 6 months after initiation of hybrid closed loop system in the CIRDIA, a French multisite out-of-hospital center3
Effect of yoga on reducing glycaemic variability in individuals with type 2 diabetes: A randomised controlled trial3
The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients3
Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010–20203
Trajectories of metabolic risk factors during the development of type 2 diabetes in Chinese adults3
Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the “Gordian Knot”?3
Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,380 adults using serial echocardiography3
Maternal autoimmune disease associated with a higher risk of offspring with type 1 diabetes: A nationwide mother-child cohort study in Taiwan3
Concise review of lipidomics in nonalcoholic fatty liver disease3
New users of sodium-glucose cotransporter 2 inhibitors are at low risk of incident pancreatic cancer: A nationwide population-based cohort study3
Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: A nationwide retrospective cohort study3
0.040927886962891